食品伙伴網(wǎng)訊 2024年2月22日,歐盟食品安全局就一種食品酶枯草桿菌金屬蛋白酶(bacillolysin)的安全性評價發(fā)布意見。
經(jīng)過評估,專家小組認為,在預期的使用條件下(蒸餾酒精生產(chǎn)除外),不能排除飲食暴露引起過敏反應的風險,但這種可能性被認為很低。根據(jù)所提供的數(shù)據(jù),評估小組得出結(jié)論,這種食品酶在預期使用條件下不會引起安全問題。部分原文報道如下:
The food enzyme bacillolysin (EC 3.4.24.28) is produced with the non-genetically modified Bacillus amyloliquefaciens strain NZYM-NB by Novozymes A/S. The production strain meets the requirements for qualified presumption of safety (QPS) approach to safety assessment. The food enzyme is intended to be used in eleven food manufacturing processes. Since residual amounts of total organic solids (TOS) are removed during two processes, dietary exposure was estimated only for the remaining nine food manufacturing processes. Exposure was estimated to be up to 1.327 mg TOS/kg body weight per day in European populations. As the production strain qualifies for the QPS approach and no issue of concern arising from the production process of the food enzyme was identified, the Panel considered that no toxicological studies other than the assessment of allergenicity were necessary. A search for the similarity of the amino acid sequence of the food enzyme to known allergens was made and no match was found. The Panel considered that the risk of allergic reactions by dietary exposure cannot be excluded (except for distilled alcohol production), but the likelihood is low. based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.
本文由食品伙伴網(wǎng)食品資訊中心編輯,有任何疑問,請聯(lián)系news@foodmate.net。